Diakonhjemmet Hospital
Oslo, 0370, Norway
NCT Number: NCT03437863
Self-management of chronic illness can be highly demanding and people need to mobilize their personal strengths in order to live well with their condition. A mobile application was designed in collaboration with people with chronic illness and health care providers with the aims to support awareness of patients' strengths and patient-provider dialogues that include strengths. The aim of the present study is to evaluate with mixed methods the perceived usefulness and usability of the application and potential effects of the application on patients.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Oslo, 0370, Norway
In this pre-post design pilot study participants will be recruited from self-management courses for people with rheumatic diseases. Before using the application participants will be asked to report their strengths in a written format. After using the mobile application to reflect on their strengths the participants will be interviewed about their experience of using the application and on the task of reflecting on their strengths. They will also be asked to fill out a questionnaire on perceived usefulness and user-friendliness. Before and after using the application the participants fill out questionnaires on emotions (Positive and Negative Affective Scale) and self-efficacy (The Arthritis Self-efficacy Scale). All interviews will be audio-taped and analyzed with a qualitative approach. Descriptive analysis will be applied for quantitative data.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Setting 1:
Inclusion criteria
No exclusion criteria
Use of a mobile application (on a borrowed device) with following features: 1) strengths reflection and identification, 2) summary of registered strengths, 3) defining goals, and 4) linking strengths to goals.
Time frame: Within an hour after using the application
Study-specific questions on perceived usefulness of the application
Time frame: Within an hour after using the application
This 10 item questionnaire measures usability. Each item has 5 response options with total score ranging from 0 to 100. Higher values represent a better outcome.
Time frame: Pre-intervention and post-intervention, within an hour after using the application
This scale measures positive and negative affect with two subscales (positive affect and negative affect). Positive affect subscale scores can range from 10-50, with higher scores representing higher levels of positive affect. Negative affect subscale scores can range from 10-50, with lower scores representing lower levels of negative affect.
Time frame: Pre-intervention and post-intervention, within an hour after using the application
This scale measures self-efficacy with two subscales with 5 response options. The "pain" subscale has 5 items and a score range from 0 to 20. The "other symptoms" subscale has 6 items and a score range from 0 to 24. Higher scores equal higher levels of self-efficacy.
Oslo University Hospital
Other
Capitalizing on the Strengths of Persons With Rheumatoid Arthritis to Improve Health and Wellness
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03813862
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Durham, North Carolina, United States
View Trial DetailsNCT06993935
Arthritis, Arthritis, Rheumatoid
Yozgat, Turkey (Türkiye)
View Trial DetailsNCT06916247
Chronic Disease, Disease Attributes
Los Angeles, California, United States
View Trial DetailsNCT03195127
Chronic Disease, Critical Illness
Baltimore, Maryland, United States
View Trial Details